—

Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) — the peer cohort

As of 2026-10-28 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Amneal Pharmaceuticals, Inc. Class A Common Stock ranks 3 of 7 in its cohort on the Closelooknet composite (56/100) — the cohort is led by Laboratorios Farmaceuticos ROVI at 62/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock 56 91 58 46 ok 2.4%
ROVI.MC Laboratorios Farmaceuticos ROVI 62 33 77 50 info 28.1%
BHC.TO Bausch Health Companies Inc 57 81 70 82 info 12.7%
GALDY GALDERMA GROUP AG 56 64 59 22 info 4.3%
IRWD Ironwood Pharmaceuticals Inc 56 37 77 83 warn 37.5%
FAGR.BR Fagron NV 54 57 56 58 info 5.7%
ALM.MC Almirall S.A. 53 30 46 63 info 24.5%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-28

Quick answers

Who are Amneal Pharmaceuticals, Inc. Class A Common Stock's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Laboratorios Farmaceuticos ROVI (ROVI.MC), Bausch Health Companies Inc (BHC.TO), GALDERMA GROUP AG (GALDY), Ironwood Pharmaceuticals Inc (IRWD), Fagron NV (FAGR.BR), Almirall S.A. (ALM.MC).

How does AMRX score against its peers?

Amneal Pharmaceuticals, Inc. Class A Common Stock's composite reads 56/100, ranking 3 of 7 in its cohort as of 2026-10-28; the cohort's highest composite is Laboratorios Farmaceuticos ROVI at 62/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.